CLINICAL_TRIALS
trial_result
· 2019-09-30
Clinical Trial Update: Fingolimod Effect on Cytokine and Chemokine Levels [Phase 4]
Summary
Phase 4 clinical trial evaluating fingolimod effects on cytokine and chemokine levels in relapsing remitting multiple sclerosis completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Relapsing Remitting Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2019-09-30